GOVX Stock Analysis: Buy, Sell, or Hold?
GOVX - GeoVax Labs, Inc. New
$2.72
-0.08 (-2.86%)
▼
5d:
-4.23%
30d:
+1214.01%
90d:
+380.57%
BUY
MODERATE Confidence
Last Updated: February 2, 2026
Earnings: Mar 26, 2026
Get Alerted When GOVX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called GOVX this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: GOVX shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: GOVX shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: GOVX is currently trading at $2.72, which is considered slightly high relative to its 30-day fair value range of $0.53 to $3.25.
Technical Outlook: Technically, GOVX is in a uptrend. The price is currently testing key support at $2.66. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $204.62 (+7208.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, GOVX is in a uptrend. The price is currently testing key support at $2.66. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $204.62 (+7208.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Fair Price Range
$0.53 -
$3.25
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
66.8%
All Signals
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 7208.0% below Wall St target ($204.62)
Fair Price Analysis
30-Day Fair Range
$0.53 -
$3.25
Current vs Fair Value
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$2.66
Resistance Level
$3.42
Current Trend
Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-0.11
Wall Street Target
$204.63
(+7208.0%)
Revenue Growth (YoY)
183.5%
Last updated: February 03, 2026 11:39 AM ET
Data refreshes hourly during market hours. Next update: 12:39 PM
Data refreshes hourly during market hours. Next update: 12:39 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is GOVX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$89 | 62 BUY |
|
INSM
Insmed Inc |
STRONG BUY
19 analysts |
$215 | 53 HOLD |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$217 | 54 HOLD |
|
ACAD
ACADIA Pharmaceuticals I… |
BUY
20 analysts |
$31 | 59 HOLD |
|
MNMD
Mind Medicine Inc |
STRONG BUY
11 analysts |
$29 | 62 BUY |
